type here...

CATEGORIES

News and Views

LATEST

Editors Choice

The Subtle Signs of Brewing Violence May Be Seen, But Not Always

Pat Farrell PhD -
Editors Choice

HT World Correspondent and Medika Editor Gil Bashe Talks with the Medika50 Influencer Who Put Everything On the Line for Patients

Gil Bashe, Medika Life Editor -
Editors Choice

Artificial Intelligence and Mental Health

Michael Hunter, MD -
Editors Choice

Has Therapeutic Touch Lost Its Way in Medicine? Or Is It Lawsuits?

Pat Farrell PhD -
Diagnostics

Babson Diagnostics, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings

Medika Life -
Press Release

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Editors Choice

If Agony and Numbness From Media War Coverage Generate Mental Aching, Why Watch?

Pat Farrell PhD -
For Doctors

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained

Medika Life -
Press Release

Cogitativo Joins the Veterans Health Administration to Address the Deferred Care Challenge Using AI-Enabled Solution

Medika Life -
Press Release

New National Survey of People Living with Bipolar I Disorder Provides Insights Into Disease-Related Challenges and the Treatment Journey

Medika Life -
1234...7Page 3 of 7

TRENDING

EDITORS CHOICE

Dallas Representative Toni Rose Fighting for Medicaid Extension for Women After Having a Baby

Dr Jeff Livingston -
Dallas Representative in the Texas House, Toni Rose, promotes HB133 to expand Medicaid coverage for postpartum people for one year in the 2021 Texas Legislative session.

Has Therapeutic Touch Lost Its Way in Medicine? Or Is It Lawsuits?

Pat Farrell PhD -
Touch has become a subject of lawsuits and medical interventions. The MeToo movement pulled touch into an unexpected, negative spotlight in our culture.

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

Retraction! A Chirping Sound Treatment for Fibromyalgia Finally Gets Flagged

James Coyne -
Why is the process of getting contentious, marketing based materials removed from Scientific publications so difficult?

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories